Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
PR Newswire
K36 Therapeutics Announces Presentation on KTX-1001 for Relapsed and Refractory Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting
December 4, 2023 -
PR Newswire
AmplifyMD Named a Winner in Fast Company’s Next Big Things in Tech
November 30, 2023 -
PR Newswire
Eleos Health and Kipu Health Announce Partnership to Deliver AI-Powered Insights to Behavioral Health Providers
November 28, 2023 -
PR Newswire
K36 Therapeutics Announces Appointment of Benjamin Winograd, MD, PhD, as Chief Medical Officer
November 15, 2023 -
The Standard
London doctors become first in the UK to ‘livestream’ surgery using robot
November 15, 2023 -
Financial Times
Biotech raises funds to find cancer treatments using transgenic mice
November 15, 2023 -
Globenewswire
T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment
November 15, 2023 -
PR Newswire
Capital Rx and Vida Health Partner to Launch Rx Activate, a High-Touch Chronic Condition Management Program
November 14, 2023 -
PR Newswire
NFlection Therapeutics Announces Positive Results from Phase 2b Study of NFX‑179 Topical Gel in the Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1
November 13, 2023 -
PR Newswire
Behavioral Health AI Leader Eleos Health Raises $40M Series B Round to Expand CareOps Automation Footprint
November 8, 2023 -
Endpoints News
AppliedVR is betting a new study could strengthen the case for insurance coverage of its VR chronic pain treatment
November 7, 2023 -
PR Newswire
OWKIN Integrates 10x Genomics Spatial Omics and Single-Cell Technologies to the MOSAIC Study
November 6, 2023 -
Business Wire
AviadoBio Announces FDA IND Clearance and Fast Track Designation for AVB-101 for the Treatment of Frontotemporal Dementia with Progranulin (GRN) Mutations
November 6, 2023 -
Endpoints News
Prime Medicine showcases its first in vivo editing data in monkeys and mice
October 30, 2023 -
Boston Business Journal
FDA lifts clinical hold on LDL-lowering drug from Verve Therapeutics
October 23, 2023 -
GlobeNewswire
NodThera announces first patients dosed in a Phase Ib/IIa cardiovascular risk trial of NLRP3 inflammasome inhibitor NT-0796
October 16, 2023 -
Business Wire
AviadoBio Announces Initiation of Phase 1/2 Clinical Trial, ASPIRE-FTD, Evaluating AVB-101 in People with Frontotemporal Dementia with GRN Mutations
October 10, 2023 -
PR Newswire
Rippl and McLean Hospital collaborate to build ‘first of its kind’ dementia training program
October 9, 2023 -
PR Newswire
Paradigm and Bristol Myers Squibb collaborate to build a new model for clinical trials
October 6, 2023 -
Globenewswire
Kyowa Kirin to Acquire Orchard Therapeutics
October 5, 2023 -
Business Wire
Aerium Therapeutics Advances Next Generation Antibodies to Protect Immunocompromised Persons Against COVID-19
October 4, 2023 -
Globenewswire
Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program Update
September 29, 2023 -
PR Newswire
Doceree raises $35 million in Series B funding, led by Creaegis with participation from Eight Roads Ventures and F-Prime Capital
September 27, 2023 -
Endpoints News
Avalyn raises $175M to test inhaler versions of IPF medicines in PhII trials
September 27, 2023 -
Globenewswire
Avalyn Raises $175 Million in Oversubscribed Series C Financing to Advance Inhaled Pulmonary Fibrosis Programs into Later Stage Clinical Studies
September 27, 2023 -
Endpoints News
Labcorp backs Adela’s $48M Series A1 to advance methylation-based head and neck cancer test
September 25, 2023 -
Wall Street Journal
All Pregnant Women Should Be Screened for Blood-Pressure Disorders, U.S. Advisers Say
September 19, 2023 -
Fierce Healthcare
Equip nabs additional investment to expand virtual eating disorder treatment services to adult patients
September 19, 2023 -
Globenewswire
Neumora Therapeutics Announces Pricing of Initial Public Offering
September 14, 2023 -
Newswire
Owkin and Tribun Health Launch Strategic Partnership to Accelerate Access to AI Solutions for Diagnosis and Pharma Research
September 11, 2023 -
Globenewswire
Beam Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of BEAM-201 in Relapsed, Refractory T-ALL/T-LL
September 5, 2023 -
Eleos Health
Eleos Health and KCare Join Forces to Improve Clinician Support with CareOps Automation
August 31, 2023 -
Boston Business Journal
Substance-use treatment startup Better Life Partners completes $26.5M Series B fundraise
August 29, 2023 -
PR Newswire
Comanche Biopharma Named by Fierce Biotech as a “Fierce 15” Biotech Company of 2023
August 28, 2023 -
PR Newswire
Comanche Biopharma Receives US FDA Fast Track Designation for CBP-4888 for the Treatment of sFlt-1 mediated pre-term preeclampsia
August 23, 2023 -
Boston Business Journal
Firefly grows in wake of healthcare disruptions in southeastern Mass.
August 22, 2023 -
Business Wire
Madaket Health Releases Provider Data Exchange to Help Payers Remain Compliant with the No Surprises Act
August 17, 2023 -
PR Newswire
TraceLink Collaborates with GS1 US to Author GS1 US Addendum Guidance and XML Examples for GS1 US DSCSA Implementation Guideline R1.3 to Support EPCIS Data Exchange
August 16, 2023 -
PR Newswire
Innovent Announces the NMPA Approval of SINTBILO® (Tafolecimab Injection) for the Treatment of Adult Patients with Primary Hypercholesterolemia and Mixed Dyslipidemia
August 16, 2023 -
BioPharma Dive
Radiopharmaceuticals for cancer: Making radiation precise
August 15, 2023 -
Business Wire
Health Plan Alliance Selects 1upHealth as Preferred Health Data Interoperability Partner
August 15, 2023 -
PR Newswire
Memorial Hermann Health System Makes a Strategic Investment in Capital Rx Customer Solutions Platform
August 10, 2023 -
Gulf Business
SoftBank-backed Proximie launches virtual robotic-assisted surgery training course
August 10, 2023 -
PR Newswire
Talkiatry and NOCD Team up to Strengthen OCD Care Journeys
August 8, 2023 -
Behavioral Health Business
Better Life Partners Lands $26.5M for Virtual SUD, Mental Health Platform
August 7, 2023 -
Globenewswire
Avalyn Pharma Expands Executive Team with Appointment of Howard M. Lazarus, MD, FCCP to the Role of Chief Medical Officer
August 7, 2023 -
MedCity News
Talkiatry, NOCD Strike Partnership To Support Patients With OCD
August 7, 2023 -
Endpoints News
Born out of Omega push for pandemic treatments, Aerium Therapeutics enters long Covid R&D
August 4, 2023 -
Owkin
With ISO certification, Owkin demonstrates commitment to utmost quality with its AI solutions for digital pathology
August 3, 2023 -
PR Newswire
Sironax Announces Closing of $200 Million Series B Financing
August 2, 2023 -
National Venture Capital Association
Member Spotlight: F-Prime Capital
July 27, 2023 -
Globenewswire
Avalyn Pharma Invited to Present at Canaccord Genuity Annual Growth Conference
July 27, 2023 -
PRWeb
Patina teams with Humana to expand reach of convenient, relationship-centered primary care for people with Medicare
July 26, 2023 -
Fierce Healthcare
VR helps brain tumor patients overcome “scanxiety” before brain scans, study finds
July 24, 2023 -
Business Wire
Bicara Therapeutics Expands Management Team with the Appointment of David Raben, M.D., as Chief Medical Officer
July 24, 2023 -
PR Newswire
AppliedVR and National Cancer Institute Collaborate on Research Evaluating Virtual Reality for Reducing Anxiety in Primary Brain Tumor Patients During Imaging Services
July 20, 2023 -
EIN Presswire
Centivo Launches Partnership with SSM Health
July 14, 2023 -
Endpoints News
Tenpoint Therapeutics launches with $70M to restore vision with stem cell therapies and ‘reprogramming’ medicines
July 12, 2023 -
Globenewswire
NodThera is first to demonstrate reduction in neuroinflammation in the clinic with brain penetrant NLRP3 inflammasome inhibitor
July 11, 2023 -
PR Newswire
Zus Health Joins Civitas Networks for Health
July 10, 2023 -
PRWeb
Patina brings innovative primary care for people 65+ to Charlotte region; designed to help individuals thrive & remain independent
July 7, 2023 -
BioSpace
Ultragenyx Announces First Patients Dosed in Phase 3 Program Evaluating Setrusumab (UX143) for the Treatment of Osteogenesis Imperfecta (OI)
July 6, 2023 -
PR Newswire
Centivo Launches Partnership with SSM Health in the Fond du Lac Market to Offer Wisconsin Businesses and Employees More Affordable, High-Quality Healthcare
July 6, 2023 -
PR Newswire
China NMPA approves RareStone’s pitolisant (Wakix) for the treatment of narcolepsy
July 4, 2023 -
BioSpace
Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration
July 3, 2023 -
PR Newswire
Innovent and IASO Bio Announce the NMPA Approval of FUCASO®, the First Fully-human BCMA CAR-T Therapy, for the Treatment of Relapsed or Refractory Multiple Myeloma
July 2, 2023 -
BioPharma Dive
F-Prime’s Ketan Patel on ‘reverse ageism’ in biotech and investing in a downturn
June 30, 2023 -
Endpoints News
K36 Therapeutics raises $70M in Series B to fund multiple myeloma research
June 29, 2023 -
PR Newswire
K36 Therapeutics Announces $70 Million Series B Financing to Fund Clinical Proof of Concept of KTX-1001, First-in-class Inhibitor of MMSET for Treatment of Multiple Myeloma Patients with Genetic Translocation (4;14)
June 28, 2023 -
Fierce Healthcare
Menopause care is still a largely untapped market. Here’s why investors and startups should dive in
June 28, 2023 -
Fox News
First AI-generated drug enters human clinical trials, targeting chronic lung disease patients
June 28, 2023 -
Financial Times
Biotech begins human trials of drug designed by artificial intelligence
June 27, 2023 -
PR Newswire
First Drug Discovered and Designed with Generative AI Enters Phase II Trials, with First Patients Dosed
June 27, 2023 -
LabPulse
Harvard Medical School, RareCyte developing multiplex imaging for clinical pathology
June 26, 2023 -
Business Wire
Invetx Appoints Dr. Marcus Remmers, Novo Holdings Partner and Animal Health Industry Leader, to Board of Directors
June 26, 2023 -
Business Wire
Castor Appoints New CFO to Drive Transformative Growth
June 26, 2023 -
PR Newswire
Innovent and RemeGen Enter into Clinical Trial Collaboration Investigating Combination Therapy of TYVYT® (sintilimab injection) and Novel ADC Candidates for Advanced Solid Tumors in China
June 25, 2023 -
Time
TIME100 Most Influential Companies 2023: Equip
June 22, 2023 -
Business Wire
Precision BioSciences Announces Oral Presentation of Positive ARCUS® Gene Editing Data at International Liver Congress 2023
June 22, 2023 -
BioCentury
ARTBIO: manufacturing strategy to lead on lead-212 radiotherapies
June 22, 2023 -
Endpoints News
Ultragenyx opens new gene therapy manufacturing site in Massachusetts
June 21, 2023 -
PR Newswire
ARTBIO Launches to Develop New Class of Alpha Radioligand Therapies Designed to Maximize Therapeutic Potential
June 21, 2023 -
Endpoints News
ARTBIO emerges with $23M to make radioligand therapies for prostate cancer, with field still in ‘early days’
June 21, 2023 -
Home Health Care News
WelbeHealth’s Michael Le On The Future Of Innovative At-Home Care Models
June 20, 2023 -
PR Newswire
Silver Cross Hospital Expands Use of Kyruus’ Award-Winning Online Scheduling Solution Across Specialties and Services
June 20, 2023 -
Endpoints News
India’s Enzene Biosciences unveils $50M New Jersey plant project, plans to hire 300
June 20, 2023 -
Globenewswire
Equip Names Nikia Bergan as the Company’s First President
June 20, 2023 -
Fierce Healthcare
Equip taps healthcare exec Nikia Bergan as new president to scale up virtual eating disorder treatment services
June 20, 2023 -
Globenewswire
Denali Therapeutics Announces Robust Reduction in Neurofilament Light (NfL) with DNL310 (ETV:IDS) Treatment in MPS II (Hunter Syndrome)
June 20, 2023 -
Globenewswire
NodThera announces positive first-in-human data for two brain penetrant NLRP3 inflammasome inhibitors
June 20, 2023
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.